CSEA3 Hybrid Annual Congress 2026
Bridging Knowledge, Improving Lives:
Allergy & Asthma in Central & Southern Europe
Farewell Message
Hybrid Event: On-site in Warsaw, Poland | Online Participation Available
Dear Colleagues and CSEA3 Friends,
On behalf of the Central and Southern European Allergy and Asthma Alliance (CSEA3) and the Congress Chairs, we would like to express our sincere gratitude for your participation in the CSEA3 Annual Congress 2026, held from 7–9 May 2026 in Warsaw, Poland, and online.
The Congress was a great success, bringing together close to 900 participants, including both on-site delegates and online attendees from across Central and Southern Europe and beyond. The high level of engagement, outstanding scientific contributions, and vibrant discussions created an exceptional scientific atmosphere throughout the meeting.
We were particularly delighted to witness the active exchange of knowledge, ideas, and experiences among clinicians, researchers, healthcare professionals, and patients represented by both international organizations (GAAPP) and national patient organizations. The Debate Arenas proved to be a unique and highly valuable platform for collaborative discussions and the development of future recommendations and expert initiatives.
We would also like to thank all speakers, chairs, moderators, patient representatives, participants, and partners whose enthusiasm and expertise contributed to the success of this hybrid event. Special thanks go to our sponsors. We would also like to express our gratitude to the Rector of Wroclaw Medical University for endorsing the Congress. Your commitment to scientific excellence and international collaboration truly reflects the mission of CSEA3 — bridging knowledge and improving lives.
We hope that the Congress inspires new ideas, strengthens existing collaborations, and creates opportunities for future joint initiatives that will continue to advance patient care and research in our region.
Thank you once again for being part of this memorable and impactful event.
We look forward to welcoming you to future CSEA3 congress, symposia and training activities.
With warm regards,
Event chairs
Marek Jutel
Ioana Agache
Dejan Dokic
Radoslaw Gawlik
Welcome Message
Hybrid Event: On-site in Warsaw, Poland | Online Participation Available
Dear Esteemed Colleagues,
On behalf of the Central and Southern European Allergy and Asthma Alliance (CSEA3), it is our great pleasure to invite you to the CSEA3 Annual Congress 2026, a hybrid event offering both on-site participation in Warsaw, Poland, and online attendance, which will take place in the vibrant capital city of Warsaw, Poland, from 7–9 May 2026.
CSEA3 Annual Congress 2026, 7–9 May 2026, Warsaw, Poland
“Bridging Knowledge, Improving Lives: Allergy & Asthma in Central & Southern Europe”.
Note: The presentations will be translated into Polish (real-time transcription).
This congress will serve as a premier platform for scientific exchange, collaboration, and networking among experts, clinicians, and researchers across Central and Southern Europe and beyond. In line with the mission of the CSEA3, the programme will highlight the latest advances in allergy, asthma, and immunology, with a focus on translating cutting-edge research into improved patient care.
Exclusive Opportunity: The Debate Arena
One of the unique highlights of the CSEA3 Annual Congress 2026 is the Debate Arena — the platform where participants can join a select group of experts to actively influence the field of allergy and asthma by shaping recommendations and guidelines.
There will be five Debate Arenas covering pivotal topics:
- Drug allergy
- Severe asthma
- Allergen immunotherapy (AIT)
- In vitro diagnostics
- Food allergy
Face-to-face attendance at the congress provides a unique opportunity to join a Debate Arena and thus engage in dynamic scientific discussions, offer input, and directly help shape best practices, and thus contribute to the advancement of the field. These arenas will subsequently evolve into Active Expert Working Groups that continue their collaborative work throughout the year, bridging the period between CSEA3 congresses.
By bringing together national societies, institutions, and healthcare professionals, the Annual Congress reflects the CSEA3’s mission to unite efforts, share knowledge, and advance excellence in allergy and asthma care across the region.
We warmly invite you to join us — either in Warsaw or online — and contribute to this important exchange of science, practice, and collaboration. Your expertise and active participation will help shape the future of allergy and asthma management in Central and Southern Europe.
We look forward to welcoming you in Warsaw, 7–9 May 2026, for what promises to be an inspiring and impactful meeting.
With warm regards,
Event chairs
Marek Jutel
Ioana Agache
Dejan Dokic
Radoslaw Gawlik
Scientific patronage
Under the honorary patronage of the Rector of Wroclaw Medical University, Poland
Endorsement statement
As a CSEA3 member, the Polish Society of Allergology (PTA) strongly endorses and actively supports the CSEA3 Annual Congress 2026. It provides scientific backing and promotes the event as a premier forum for innovation, collaboration, and knowledge exchange in allergology and asthma across Central and Southern Europe.
Quality assurance
Infarma certificate
We are pleased to announce that our event has officially received the Infarma Certificate. This recognition confirms that the event fully complies with the highest standards of transparency, integrity, and ethical collaboration set by Infarma
Partner
Patient Organisation Partnership
For years, the Foundation Centre for Fighting Allergy has been committed to educating patients and the wider public, as well as undertaking systemic initiatives aimed at improving the quality of life for people with allergic diseases in Poland. We regard the partnership with CSEA3 as an alignment of the congress’s scientific mission with the patient perspective — essential for implementing modern standards of allergy and asthma treatment across European countries.
